For decades, millions of women going through menopause were told to avoid hormone replacement therapy based on a 2002 study that linked estrogen use to elevated risks of heart attack and stroke, and prescriptions plummeted. Last year, the FDA reversed course, removing the longstanding black box warning from estrogen products
